Alireza shokrgozar; yasamin nekoonam; Farkhondeh Nikkhah
Abstract
anxiety in people with coronary artery disease. Method: The statistical population of the present study was all patients referred to counseling and psychology centers in Tehran Region 5 in 2020. In the present study, 18 people were randomly selected from Nedaye Daroon Psychological Counseling Center ...
Read More
anxiety in people with coronary artery disease. Method: The statistical population of the present study was all patients referred to counseling and psychology centers in Tehran Region 5 in 2020. In the present study, 18 people were randomly selected from Nedaye Daroon Psychological Counseling Center and placed in two experimental and control groups. Participants were assessed using the Petersburg (1989) Beck Anxiety Inventory (1988) Sleep Quality Scale. The participants in the experimental group were then treated with neurofeedback for 15 one-hour sessions and the control group did not receive any training. Data were analyzed using analysis of covariance. Results: The results showed that the differences between the control and experimental groups were effective in the components of sleep quality, sleep disorders, sleeping pills, and daily dysfunction. In other words, neurofeedback therapy reduced the scores of these components, but this treatment had an effect on other components. Was not significant and also the number of anxiety scores in the post-test of the experimental group decreased significantly. Conclusion: Considering the effectiveness of neurofeedback therapy on increasing the quality of sleep and reducing anxiety in individuals, this treatment can be used in the form of treatment programs in coronary conditions.
